Israel Englander Oramed Pharmaceuticals Inc. Transaction History

Millennium Management LLC

$192 Billion
Q4 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Millennium Management LLC holds 24,381 shares of ORMP stock, worth $59,733. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,381

Previous 46,667 47.76%

Holding current value

$59,733

Previous $113,000 47.79%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$2.17 - $2.52 $48,360 - $56,160	-22,286 Reduced 47.76%	24,381 $59,000
Q3 2024 Nov 14, 2024	BUY	$2.21 - $2.63 $60,134 - $71,562	27,210 Added 139.85%	46,667 $113,000
Q2 2024 Aug 14, 2024	BUY	$2.07 - $2.83 $40,275 - $55,063	19,457 New	19,457 $50,000
Q2 2023 Aug 14, 2023	SELL	$2.12 - $4.47 $184,758 - $389,560	-87,150 Reduced 52.57%	78,620 $281,000
Q1 2023 May 15, 2023	SELL	$1.93 - $13.1 $626,155 - $4.25 Million	-324,433 Reduced 66.18%	165,770 $361,000
Q4 2022 Feb 14, 2023	SELL	$5.88 - $12.03 $75,428 - $154,320	-12,828 Reduced 2.55%	490,203 $5.9 Million
Q3 2022 Nov 14, 2022	SELL	$4.6 - $9.91 $355,819 - $766,558	-77,352 Reduced 13.33%	503,031 $3.26 Million
Q2 2022 Aug 15, 2022	BUY	$3.72 - $9.0 $806,581 - $1.95 Million	216,823 Added 59.64%	580,383 $2.66 Million
Q1 2022 May 16, 2022	SELL	$8.19 - $13.89 $3.26 Million - $5.53 Million	-398,010 Reduced 52.26%	363,560 $3.15 Million
Q4 2021 Feb 14, 2022	BUY	$12.98 - $29.75 $8.99 Million - $20.6 Million	692,384 Added 1000.76%	761,570 $10.9 Million
Q3 2021 Nov 15, 2021	SELL	$12.13 - $23.82 $1.6 Million - $3.15 Million	-132,034 Reduced 65.62%	69,186 $1.52 Million
Q2 2021 Aug 16, 2021	BUY	$8.34 - $14.59 $376,117 - $657,979	45,098 Added 28.89%	201,220 $2.69 Million
Q1 2021 May 17, 2021	BUY	$4.22 - $11.33 $559,593 - $1.5 Million	132,605 Added 563.87%	156,122 $1.59 Million
Q4 2020 Feb 16, 2021	SELL	$2.48 - $4.64 $115,486 - $216,070	-46,567 Reduced 66.44%	23,517 $100,000
Q3 2020 Nov 16, 2020	BUY	$2.58 - $4.16 $180,816 - $291,549	70,084 New	70,084 $183,000
Q2 2020 Aug 14, 2020	SELL	$2.87 - $4.12 $37,571 - $53,934	-13,091 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$2.6 - $5.5 $34,036 - $72,000	13,091 New	13,091 $40,000
Q4 2019 Feb 14, 2020	SELL	$2.43 - $5.74 $38,325 - $90,531	-15,772 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$2.88 - $3.96 $45,423 - $62,457	15,772 New	15,772 $50,000
Q1 2018 May 15, 2018	SELL	$6.51 - $9.14 $103,176 - $144,859	-15,849 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$7.95 - $11.15 $125,999 - $176,716	15,849	15,849 $143,000

Others Institutions Holding ORMP

# of Institutions

Shares Held

8.1M

Call Options Held

Put Options Held

18.1K

View Full List

About ORAMED PHARMACEUTICALS INC.

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $95.1M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

More about ORMP

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account